{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T17:55:37Z","timestamp":1771955737039,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,12,29]],"date-time":"2012-12-29T00:00:00Z","timestamp":1356739200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Assist Reprod Genet"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s10815-012-9919-3","type":"journal-article","created":{"date-parts":[[2012,12,28]],"date-time":"2012-12-28T05:01:12Z","timestamp":1356670872000},"page":"239-245","source":"Crossref","is-referenced-by-count":18,"title":["Comparing the efficacy of urinary and recombinant hCG on oocyte\/follicle ratio to trigger ovulation in women undergoing intracytoplasmic sperm injection cycles: a randomized controlled trial"],"prefix":"10.1007","volume":"30","author":[{"given":"Tahereh","family":"Madani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ladan","family":"Mohammadi Yeganeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Ezabadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Hasani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Chehrazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,12,29]]},"reference":[{"issue":"2","key":"9919_CR1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1210\/edrv-17-2-121","volume":"17","author":"A Gougeon","year":"1996","unstructured":"Gougeon A. Regulation of ovarian follicular development in primates: facts and hypotheses. Endocr Rev. 1996;17(2):121\u201355.","journal-title":"Endocr Rev"},{"key":"9919_CR2","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1146\/annurev.bi.50.070181.002341","volume":"50","author":"JG Pierce","year":"1981","unstructured":"Pierce JG, Parsons TF. Glycoprotein hormones: structure and function. Annu Rev Biochem. 1981;50:465\u201395.","journal-title":"Annu Rev Biochem"},{"issue":"6","key":"9919_CR3","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0015-0282(01)01803-9","volume":"75","author":"The International Recombinant Human Chorionic Gonadotropin Study Group","year":"2001","unstructured":"The International Recombinant Human Chorionic Gonadotropin Study Group. Induction of ovulation in World Health Organization group II anovulatory women undergoing follicular stimulation with recombinant human follicle-stimulating hormone: a comparison of recombinant human chorionic gonadotropin (rhCG) and urinary hCG. Fertil Steril. 2001;75(6):1111\u20138.","journal-title":"Fertil Steril"},{"issue":"7","key":"9919_CR4","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1093\/humrep\/14.7.1703","volume":"14","author":"J Penarrubia","year":"1999","unstructured":"Penarrubia J, Balasch J, Fabregues F, Creus M, Civico S, Vanrell JA. Recurrent empty follicle syndrome successfully treated with recombinant human chorionic gonadotrophin. Hum Reprod. 1999;14(7):1703\u20136.","journal-title":"Hum Reprod"},{"issue":"Suppl 1","key":"9919_CR5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/humrep\/11.suppl_5.95","volume":"11","author":"E Loumaye","year":"1996","unstructured":"Loumaye E, Martineau I, Piazzi A, et al. Clinical assessment of human gonadotrophins produced by recombinant DNA technology. Hum Reprod. 1996;11 Suppl 1:95\u2013107. discussion 17-9.","journal-title":"Hum Reprod"},{"issue":"4","key":"9919_CR6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10815-005-4911-9","volume":"22","author":"V Abdelmassih","year":"2005","unstructured":"Abdelmassih V, Oliveira FG, Goncalves SP, Varella AD, Diamond MP, Abdelmassih R. A prospective, randomized and blinded comparison between 10,000\u00a0IU urinary and 250 microg recombinant human chorionic gonadotropin for oocyte maturation in in vitro fertilization cycles. J Assist Reprod Genet. 2005;22(4):149\u201353.","journal-title":"J Assist Reprod Genet"},{"issue":"1","key":"9919_CR7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0015-0282(01)01851-9","volume":"76","author":"P Chang","year":"2001","unstructured":"Chang P, Kenley S, Burns T, et al. Recombinant human chorionic gonadotropin (rhCG) in assisted reproductive technology: results of a clinical trial comparing two doses of rhCG (Ovidrel) to urinary hCG (Profasi) for induction of final follicular maturation in in vitro fertilization-embryo transfer. Fertil Steril. 2001;76(1):67\u201374.","journal-title":"Fertil Steril"},{"issue":"6","key":"9919_CR8","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/j.fertnstert.2007.10.015","volume":"90","author":"P Kovacs","year":"2008","unstructured":"Kovacs P, Kovats T, Bernard A, Zadori J, Szmatona G, Kaali SG. Comparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization. Fertil Steril. 2008;90(6):2133\u20137.","journal-title":"Fertil Steril"},{"issue":"2","key":"9919_CR9","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S1472-6483(10)61927-X","volume":"4","author":"I Trinchard-Lugan","year":"2002","unstructured":"Trinchard-Lugan I, Khan A, Porchet HC, Munafo A. Pharmacokinetics and pharmacodynamics of recombinant human chorionic gonadotrophin in healthy male and female volunteers. Reprod Biomed Online. 2002;4(2):106\u201315.","journal-title":"Reprod Biomed Online"},{"issue":"6","key":"9919_CR10","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1093\/humrep\/15.6.1305","volume":"15","author":"GL Driscoll","year":"2000","unstructured":"Driscoll GL, Tyler JP, Hangan JT, Fisher PR, Birdsall MA, Knight DC. A prospective, randomized, controlled, double-blind, double-dummy comparison of recombinant and urinary HCG for inducing oocyte maturation and follicular luteinization in ovarian stimulation. Hum Reprod. 2000;15(6):1305\u201310.","journal-title":"Hum Reprod"},{"issue":"6","key":"9919_CR11","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.fertnstert.2006.11.025","volume":"87","author":"K Sakhel","year":"2007","unstructured":"Sakhel K, Khedr M, Schwark S, Ashraf M, Fakih MH, Abuzeid M. Comparison of urinary and recombinant human chorionic gonadotropin during ovulation induction in intrauterine insemination cycles: a prospective randomized clinical trial. Fertil Steril. 2007;87(6):1357\u201362.","journal-title":"Fertil Steril"},{"issue":"7","key":"9919_CR12","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1093\/humrep\/15.7.1446","volume":"15","author":"The European Recombinant Human Chorionic Gonadotrophin Study Group","year":"2000","unstructured":"The European Recombinant Human Chorionic Gonadotrophin Study Group. Induction of final follicular maturation and early luteinization in women undergoing ovulation induction for assisted reproduction treatment--recombinant HCG versus urinary HCG. The European Recombinant Human Chorionic Gonadotrophin Study Group. Hum Reprod. 2000;15(7):1446\u201351.","journal-title":"Hum Reprod"},{"issue":"7","key":"9919_CR13","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1016\/j.fertnstert.2010.04.077","volume":"94","author":"EG Papanikolaou","year":"2010","unstructured":"Papanikolaou EG, Fatemi H, Camus M, et al. Higher birth rate after recombinant hCG triggering compared with urinary-derived hCG in single-blastocyst IVF antagonist cycles: a randomized controlled trial. Fertil Steril. 2010;94(7):2902\u20134.","journal-title":"Fertil Steril"},{"key":"9919_CR14","first-page":"CD003719","volume":"4","author":"MA Youssef","year":"2011","unstructured":"Youssef MA, Al-Inany HG, Aboulghar M, Mansour R, Abou-Setta AM. Recombinant versus urinary human chorionic gonadotrophin for final oocyte maturation triggering in IVF and ICSI cycles. Cochrane Database Syst Rev. 2011;(4):CD003719.","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"9919_CR15","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1210\/jc.2004-2169","volume":"90","author":"CC Chan","year":"2005","unstructured":"Chan CC, Ng EH, Tang OS, Yeung WS, Lau EY, Ho PC. A prospective, randomized, double-blind study to compare two doses of recombinant human chorionic gonadotropin in inducing final oocyte maturity and the hormonal profile during the luteal phase. J Clin Endocrinol Metab. 2005;90(7):3933\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"9919_CR16","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0301-2115(03)00010-1","volume":"109","author":"ED Littman","year":"2003","unstructured":"Littman ED, Milki AA. The combination of urinary and recombinant HCG improves outcome in patients with decreased oocyte\/follicle ratio in previous cycles. Eur J Obstet Gynecol Reprod Biol. 2003;109(1):60\u20132.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"9919_CR17","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1749-6632.1988.tb22263.x","volume":"541","author":"LL Veeck","year":"1988","unstructured":"Veeck LL. Oocyte assessment and biological performance. Ann N Y Acad Sci. 1988;541:259\u201374.","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"9919_CR18","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10815-009-9318-6","volume":"26","author":"M Rezazadeh Valojerdi","year":"2009","unstructured":"Rezazadeh Valojerdi M, Eftekhari-Yazdi P, Karimian L, Hassani F, Movaghar B. Vitrification versus slow freezing gives excellent survival, post warming embryo morphology and pregnancy outcomes for human cleaved embryos. J Assist Reprod Genet. 2009;26(6):347\u201354.","journal-title":"J Assist Reprod Genet"},{"issue":"4","key":"9919_CR19","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1210\/jcem-57-4-792","volume":"57","author":"JD Hoff","year":"1983","unstructured":"Hoff JD, Quigley ME, Yen SS. Hormonal dynamics at midcycle: a reevaluation. J Clin Endocrinol Metab. 1983;57(4):792\u20136.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"9919_CR20","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1093\/humrep\/12.11.2385","volume":"12","author":"GI Meniru","year":"1997","unstructured":"Meniru GI, Craft IL. Evidence from a salvaged treatment cycle supports an aetiology for the empty follicle syndrome that is related to terminal follicular developmental events. Hum Reprod. 1997;12(11):2385\u20137.","journal-title":"Hum Reprod"},{"issue":"3","key":"9919_CR21","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/mrd.1080280313","volume":"28","author":"DM Phillips","year":"1991","unstructured":"Phillips DM, Dekel N. Maturation of the rat cumulus-oocyte complex: structure and function. Mol Reprod Dev. 1991;28(3):297\u2013306.","journal-title":"Mol Reprod Dev"},{"issue":"5","key":"9919_CR22","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0015-0282(03)00173-0","volume":"79","author":"M Ludwig","year":"2003","unstructured":"Ludwig M, Doody KJ, Doody KM. Use of recombinant human chorionic gonadotropin in ovulation induction. Fertil Steril. 2003;79(5):1051\u20139.","journal-title":"Fertil Steril"},{"issue":"9","key":"9919_CR23","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1093\/oxfordjournals.humrep.a136281","volume":"10","author":"F Zegers-Hochschild","year":"1995","unstructured":"Zegers-Hochschild F, Fernandez E, Mackenna A, Fabres C, Altieri E, Lopez T. The empty follicle syndrome: a pharmaceutical industry syndrome. Hum Reprod. 1995;10(9):2262\u20135.","journal-title":"Hum Reprod"},{"key":"9919_CR24","doi-asserted-by":"crossref","first-page":"S224","DOI":"10.1016\/j.fertnstert.2008.07.543","volume":"90","author":"S Krotz","year":"2008","unstructured":"Krotz S, Bhagavath B, Hackett R, Pagidas K, Carson S, Robins J. Comparison of IVF retrieval and clinical outcomes in 744 patients using recombinant versus urinary human chorionic gonadotropins to trigger ovulation. Fertil Steril. 2008;90:S224\u2013S5.","journal-title":"Fertil Steril"},{"issue":"3","key":"9919_CR25","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S1472-6483(10)61433-2","volume":"13","author":"ML Uhler","year":"2006","unstructured":"Uhler ML, Beltsos AN, Grotjan HE, Lederer KJ, Lifchez AS. Age-matched comparison of recombinant and urinary HCG for final follicular maturation. Reprod Biomed Online. 2006;13(3):315\u201320.","journal-title":"Reprod Biomed Online"},{"key":"9919_CR26","first-page":"CD003719","volume":"2","author":"HG Al-Inany","year":"2005","unstructured":"Al-Inany HG, Aboulghar M, Mansour R, Proctor M. Recombinant versus urinary human chorionic gonadotrophin for ovulation induction in assisted conception. Cochrane Database Syst Rev. 2005;(2):CD003719.","journal-title":"Cochrane Database Syst Rev"},{"issue":"9\u201310","key":"9919_CR27","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s10815-008-9262-x","volume":"25","author":"A Farrag","year":"2008","unstructured":"Farrag A, Costantini A, Manna C, Grimaldi G. Recombinant HCG for triggering ovulation increases the rate of mature oocytes in women treated for ICSI. J Assist Reprod Genet. 2008;25(9\u201310):461\u20136.","journal-title":"J Assist Reprod Genet"},{"key":"9919_CR28","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1100\/2011\/409140","volume":"11","author":"J Zeke","year":"2011","unstructured":"Zeke J, Kanyo K, Zeke H, et al. Pregnancy rates with recombinant versus urinary human chorionic gonadotropin in in vitro fertilization: an observational study. Sci World J. 2011;11:1781\u20137.","journal-title":"Sci World J"},{"key":"9919_CR29","doi-asserted-by":"crossref","unstructured":"Clua E, Martinez F, Tur R, Sanmartin P, Chueca A, Barri PN. Triggering ovulation with 250 mug or 500 mug of r-hCG in oocyte donors treated with antagonist protocol has no effect on the number of mature oocytes retrieved: a randomized clinical trial. Gynecol Endocrinol. 2012;28(9):678\u201381.","DOI":"10.3109\/09513590.2011.652244"},{"issue":"6","key":"9919_CR30","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/j.fertnstert.2009.08.026","volume":"93","author":"S Kahraman","year":"2010","unstructured":"Kahraman S, Karlikaya G, Kavrut M, Karagozoglu H. A prospective, randomized, controlled study to compare two doses of recombinant human chorionic gonadotropin in serum and follicular fluid in woman with high body mass index. Fertil Steril. 2010;93(6):2084\u20137.","journal-title":"Fertil Steril"}],"container-title":["Journal of Assisted Reproduction and Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-012-9919-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10815-012-9919-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-012-9919-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T21:19:55Z","timestamp":1559251195000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10815-012-9919-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,29]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["9919"],"URL":"https:\/\/doi.org\/10.1007\/s10815-012-9919-3","relation":{},"ISSN":["1058-0468","1573-7330"],"issn-type":[{"value":"1058-0468","type":"print"},{"value":"1573-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,29]]}}}